• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Yesterday
In the last 7 days
Access to SMA therapy: Iman’s Story Knowledge Ecology International13:07 27-Jul-21
Roche records 8% increase in group sales for H1 2021 Pharmaceutical Technology12:28 23-Jul-21
Roche Deals With Huge Gantenerumab Curiosity At H1 Update Scrip Pharma Intelligence09:15 23-Jul-21
Roche takes the Tim-3 battle to Novartis Evaluate Group15:15 22-Jul-21
Safety alert on Accu-Chek Performa test strips (with photo) The Government of Hong Kong Special Administrative Region (Press Release)13:32 22-Jul-21
In the last month
Shortages of tocilizumab (Actemra) medicines Therapeutic Goods Administration - Australian Government12:40 21-Jul-21
IBMS supports call for increased diagnostics investment The Institute of Biomedical Science (IBMS)09:27 21-Jul-21
Actemra Access: Roche Open To Partnering Patent Pools Scrip Pharma Intelligence09:39 16-Jul-21
Pipeline Catalysts Key Focus For Roche’s H1 Update Scrip Pharma Intelligence12:56 15-Jul-21
Roche Stock Could Be an Alzheimer's Winner Barron's Online16:31 14-Jul-21
Shot in the arm for Roche’s Tocilizumab The Hindu Business Line16:12 8-Jul-21
view more headlines
28 Jul 13:42

Roche News

NewsNow brings you the latest news from the world’s most trusted sources on Roche pharmaceuticals, a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. NewsNow aims to be the world’s most accurate and comprehensive Roche news aggregator, bringing you the latest headlines automatically and continuously 24/7. N.B. Relevance is automatically assessed so some headlines not qualifying as Roche news might appear - please feel free to contact us regarding any persistent issues.
Read more

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.